<PAGE>
EXHIBIT 1
In accordance with Rule 13d-1(k) of Regulation 13D-G of the Securities Exchange
Act of 1934, as amended, Tradewinds Financial Corporation, Tradewinds Debt
Strategies Fund, L.P., Tradewinds Offshore Fund, L.P., Feehan Partners, L.P.,
Atlas Defined Contribution Plan, Robert Scannell Roth IRA, Robert W. Scannell
and Scott Peters agree to the joint filing on behalf of each of them of this
Statement on Schedule 13D (including any and all amendments thereto) relating to
the Common Stock, $0.001 par value per share, of Shaman Pharmaceuticals, Inc.
Dated as of December 6, 2000
TRADEWINDS FINANCIAL CORPORATION
By: /s/ Robert Scannell
----------------------------------------------
Name: Robert Scannell
Title: President
TRADEWINDS DEBT STRATEGIES FUND, L.P.
By: /s/ Robert Scannell
----------------------------------------------
Name: Robert Scannell
Title: General Partner
TRADEWINDS OFFSHORE FUND, L.P.
By: /s/ Robert Scannell
----------------------------------------------
Name: Robert Scannel
Title: General Partner
FEEHAN PARTNERS, L.P.
By: /s/ Robert Scannell
----------------------------------------------
Name: Robert Scannell
Title: General Partner
Page 1 of 2
<PAGE>
ATLAS DEFINED CONTRIBUTION PLAN
By: /s/ Scott Peters
----------------------------------------------
Name: Scott Peters
Title: Trustee
ROBERT SCANNELL ROTH IRA
By: /s/ Robert Scannell
----------------------------------------------
Name: Robert Scannell
Title: Trustee
/s/ Robert Scannell
-------------------------------------------------
Robert W. Scannell
/s/ Scott Peters
-------------------------------------------------
Scott P. Peters
Page 2 of 2
